Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04349267
What this trial is testing

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Bristol-Myers Squibb 44
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Early research (Phase 1)Active Not RecruitingNCT05393427
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Urinary TumorsOther Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 4
Testing effectiveness (Phase 2)Study completedNCT00003542
What this trial is testing

Interferon Alfa in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center 58
Not applicableStudy completedNCT04043975
What this trial is testing

Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan

Who this might be right for
Advanced or Metastatic Renal Cell Carcinoma
Bristol-Myers Squibb 286
Testing effectiveness (Phase 2)Ended earlyNCT00203866
What this trial is testing

Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Chicago 40
Testing effectiveness (Phase 2)Study completedNCT02799095
What this trial is testing

The Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Mural Oncology, Inc 243
Early research (Phase 1)Looking for participantsNCT06026410
What this trial is testing

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Who this might be right for
Solid Tumors With HRAS AlterationsNon Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+4 more
Kura Oncology, Inc. 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05241561
What this trial is testing

Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients

Who this might be right for
Cancer of Kidney
Centre Hospitalier Universitaire de Besancon 24
Early research (Phase 1)Study completedNCT01079286
What this trial is testing

Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers

Who this might be right for
Renal Cell CancerCancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 18
Early research (Phase 1)Looking for participantsNCT05865002
What this trial is testing

A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)

Who this might be right for
Relapsed Malignant Solid Neoplasm
Aurigene Discovery Technologies Limited 50
Testing effectiveness (Phase 2)Ended earlyNCT02608268
What this trial is testing

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancies
Novartis Pharmaceuticals 252
Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT00005069
What this trial is testing

Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00045370
What this trial is testing

Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00095186
What this trial is testing

Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Agennix 40
Testing effectiveness (Phase 2)Study completedNCT00903175
What this trial is testing

Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Novartis Pharmaceuticals 471
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Study completedNCT04495257
What this trial is testing

APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)

Who this might be right for
Advanced MelanomaRenal Cell Carcinoma
Yale University 26
Large-scale testing (Phase 3)Study completedNCT04394975
What this trial is testing

Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer

Who this might be right for
Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
Shanghai Junshi Bioscience Co., Ltd. 421
Next Page